Nxn has released a press release.
Quarterly Report - Q2 FY26
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nexsen
- $500k govt grant expands GBS project to neonates
- Investor Presentation
- Nexsen Appoints Global Clinical Leader to the Board
- Quarterly Report - Q1 FY26
- Nexsen launches clinical trial for GBS Rapid Sensor
Later from Nexsen
- Half Yearly Report and Accounts
- FDA feedback derisks US approval pathway for StrepSure
- Nexsen accelerates global rollout for StrepSure
- HK$6 million grant awarded to advance Asia-Pacific execution
- QMS milestone achieved
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen